Online citations, reference lists, and bibliographies.
← Back to Search

PET/MRI Dual-Modality Tumor Imaging Using Arginine-Glycine-Aspartic (RGD)–Conjugated Radiolabeled Iron Oxide Nanoparticles

Ha-young Lee, Z. Li, K. Chen, Andrew R. Hsu, C. Xu, J. Xie, S. Sun, X. Chen
Published 2008 · Chemistry, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
The purpose of this study was to develop a bifunctional iron oxide (IO) nanoparticle probe for PET and MRI scans of tumor integrin αvβ3 expression. Methods: Polyaspartic acid (PASP)–coated IO (PASP-IO) nanoparticles were synthesized using a coprecipitation method, and particle size and magnetic properties were measured. A phantom study was used to assess the efficacy of PASP-IO as a T2-weighted MRI contrast agent. PASP-IO nanoparticles with surface amino groups were coupled to cyclic arginine-glycine-aspartic (RGD) peptides for integrin αvβ3 targeting and macrocyclic 1,4,7,10-tetraazacyclododecane-N,N′,N″,N′″,-tetraacetic acid (DOTA) chelators for PET after labeling with 64Cu. IO nanoparticle conjugates were further tested in vitro and in vivo to determine receptor targeting efficacy and feasibility for dual PET/MRI. Results: PASP-IO nanoparticles made by single-step reaction have a core size of 5 nm with a hydrodynamic diameter of 45 ± 10 nm. The saturation magnetization of PASP-IO nanoparticles is about 117 emu/g of iron, and the measured r2 and r2* are 105.5 and 165.5 (s·mM)−1, respectively. A displacement competitive binding assay indicates that DOTA-IO-RGD conjugates bound specifically to integrin αvβ3 in vitro. Both small-animal PET and T2-weighted MRI show integrin-specific delivery of conjugated RGD-PASP-IO nanoparticles and prominent reticuloendothelial system uptake. Conclusion: We have successfully developed an IO-based nanoprobe for simultaneous dual PET and MRI of tumor integrin expression. The success of this bifunctional imaging approach may allow for earlier tumor detection with a high degree of accuracy and provide further insight into the molecular mechanisms of cancer.
This paper references
In vivo Near-Infrared Fluorescence Imaging of Integrin αvβ3 in Brain Tumor Xenografts
X. Chen (2004)
Lanthanide-loaded liposomes for multimodality imaging and therapy.
S. W. Zielhuis (2006)
Synthesis of a novel PEG-block-poly(aspartic acid-stat-phenylalanine) copolymer shows potential for formation of a micellar drug carrier.
K. Prompruk (2005)
Specific targeting of tumor angiogenesis by RGD-conjugated ultrasmall superparamagnetic iron oxide particles using a clinical 1.5-T magnetic resonance scanner.
Chunfu Zhang (2007)
Retrospective Registration of PET and MR Brain Images: An Algorithm and Its Stereotactic Validation
Y. Ge (1994)
Characterization of normal and infarcted rat myocardium using a combination of small-animal PET and clinical MRI.
T. Higuchi (2007)
Multivalent effects of RGD peptides obtained by nanoparticle display.
X. Montet (2006)
Detection of Recurrent Pancreatic Cancer: Comparison of FDG-PET with CT/MRI
J. Ruf (2005)
Contemporaneous positron emission tomography and MR imaging at 1.5 T
K. Farahani (1999)
Fast and robust registration of PET and MR images of human brain
J. Cizek (2004)
A combined PET/CT scanner: the path to true image fusion.
D. Townsend (2002)
A combined PET/CT scanner for clinical oncology.
T. Beyer (2000)
Phantom validation of coregistration of PET and CT for image-guided radiotherapy.
William C. Lavely (2004)
Imaging chemically modified adenovirus for targeting tumors expressing integrin alphavbeta3 in living mice with mutant herpes simplex virus type 1 thymidine kinase PET reporter gene.
Zhengming Xiong (2006)
Molecular imaging of cancer with positron emission tomography
S. Gambhir (2002)
MicroPET: a high resolution PET scanner for imaging small animals
S. Cherry (1996)
Coronary MR angiography: experimental results with a monomer-stabilized blood pool contrast medium.
M. Taupitz (2002)
Image registration by maximization of combined mutual information and gradient information
J. Pluim (2000)
The application of PET-MR image registration in the brain.
R. Myers (2002)
Nanoplatforms for targeted molecular imaging in living subjects.
W. Cai (2007)
Magnetic resonance and fluorescence based molecular imaging technologies.
D. Sosnovik (2005)
PET-CT detection of abdominal recurrence of ovarian cancer: radiologic–surgical correlation
H. Pannu (2003)
First clinical trial of a new superparamagnetic iron oxide for use as an oral gastrointestinal contrast agent in MR imaging.
P. Hahn (1990)
Peptide-labeled near-infrared quantum dots for imaging tumor vasculature in living subjects.
W. Cai (2006)
Ferrimagnetic susceptibility contrast agents.
T. Bach-Gansmo (1993)
microPET Imaging of Glioma Integrin αvβ3 Expression Using 64Cu-Labeled Tetrameric RGD Peptide
Y. Wu (2005)
Simultaneous PET and MR imaging.
Y. Shao (1997)
Use of PET for monitoring cancer therapy and for predicting outcome.
W. Weber (2005)
Performance evaluation of the microPET focus: a third-generation microPET scanner dedicated to animal imaging.
Y. Tai (2005)
Renal clearance of quantum dots
H. Choi (2007)
Dual-modality PET/CT tomography for clinical oncology.
T. Beyer (2002)
Value of blood pool contrast agents in magnetic resonance angiography of the pelvis and lower extremities
M. Saeed (1998)

This paper is referenced by
Synthesis and Characterization of Silver Nanoparticles using leaf extract of Azadirachta indica
Tamasa Panigrahi (2013)
Development of a complementary PET/MR dual-modal imaging probe for targeting prostate-specific membrane antigen (PSMA).
Sung-Hyun Moon (2016)
Simultaneous PET and MR Imaging of the Human Brain
C. Catana (2011)
Nanobioremediation Technologies for Potential Application in Environmental Cleanup
S. Sinha (2020)
Radioisotopes and Nanomedicine
N. Sheets (2011)
Multimodality Imaging of Integrin αvβ3 Expression
Yin Zhang (2011)
Engineering of radiolabeled iron oxide nanoparticles for dual-modality imaging.
Fanrong Ai (2016)
Gd3+ complex-modified NaLuF4-based upconversion nanophosphors for trimodality imaging of NIR-to-NIR upconversion luminescence, X-Ray computed tomography and magnetic resonance.
A. Xia (2012)
Development of copper based drugs, radiopharmaceuticals and medical materials
P. Szymański (2012)
An optimised spectrophotometric assay for convenient and accurate quantitation of intracellular iron from iron oxide nanoparticles
M. Hedayati (2018)
Targeted magnetic iron oxide nanoparticles for tumor imaging and therapy
Xiang-hong Peng (2008)
Synthesis, functionalization, and biomedical applications of multifunctional magnetic nanoparticles.
R. Hao (2010)
Development of a novel iron oxide encapsulated prostate-specific membrane antigen (PSMA) targeting nanoparticle as a dual-modality imaging probe for PET and MRI
Sung-Hyun Moon (2016)
Innovative Magnetic Nanoparticles for PET/MRI Bimodal Imaging
G. Thomas (2019)
Drug Delivery Systems and Theranostic use in Nuclear Medicine
G. Vural (2015)
Radiolabelled nanoparticles: novel classification of radiopharmaceuticals for molecular imaging of cancer
S. F. Mirshojaei (2016)
Preclinical Applications of Magnetic Resonance Imaging in Oncology.
W. Reichardt (2020)
Nanotheranostics-Based Imaging for Cancer Treatment Monitoring
T. Miao (2019)
Enhancing PET Signal at Target Tissue in Vivo: Dendritic and Multimeric Tris(hydroxypyridinone) Conjugates for Molecular Imaging of αvβ3 Integrin Expression with Gallium-68
Cinzia Imberti (2017)
Polyoxometalate-Based Radiosensitization Platform for Treating Hypoxic Tumors by Attenuating Radioresistance and Enhancing Radiation Response.
Yuan Yong (2017)
Design of novel protein-based MRI contrast agernets with high relaxivity and stabilty for biomedical imaging
Shenghui Xue (2013)
Bimodal thrombus imaging: simultaneous PET/MR imaging with a fibrin-targeted dual PET/MR probe--feasibility study in rat model.
R. Uppal (2011)
Nuclear Imaging with Nanoparticles
Ali Azhdarinia (2014)
Magnetic/upconversion fluorescent NaGdF4:Yb,Er nanoparticle-based dual-modal molecular probes for imaging tiny tumors in vivo.
C. Liu (2013)
A Dual PET/MR Imaging Nanoprobe: 124I Labeled Gd3N@C80
Jianqiao Luo (2012)
ICP-MS analysis of lanthanide-doped nanoparticles: A quantitative and multiplexing approach to investigate biodistribution, blood clearance, and targeting
S. Crayton (2012)
Fluorescent/magnetic micro/nano-spheres based on quantum dots and/or magnetic nanoparticles: preparation, properties, and their applications in cancer studies.
Cong-Ying Wen (2016)
Image-Based Analysis of Tumor Localization After Intra-Arterial Delivery of Technetium-99m-Labeled SPIO Using SPECT/CT and MRI
I. J. Lee (2017)
Facile synthesis of multifunctional nanocomposites with good compatibility for efficient dual-mode T1 and T2 magnetic resonance imaging and gene delivery
Hui-Hui Xiang (2019)
Convenient synthesis of heterobifunctional poly(ethylene glycol) suitable for the functionalization of iron oxide nanoparticles for biomedical applications.
S. Passemard (2013)
Synthesis, colloidal stability and 64Cu labeling of iron oxide nanoparticles bearing different macrocyclic ligands
J. Barreto (2011)
Functionalized nanomaterials: their use as contrast agents in bioimaging: mono- and multimodal approaches
Quentin Le Tréquesser (2013)
See more
Semantic Scholar Logo Some data provided by SemanticScholar